UnitedHealth Group (NYSE:UNH) Trading 3.2% Higher - Still a Buy?

robot
Abstract generation in progress

UnitedHealth Group (NYSE:UNH) traded up 3.2% midday Friday, reaching $293.33, despite missing revenue estimates and facing mixed analyst revisions. While Optum’s expansion and some earnings forecast upgrades provide positive sentiment, concerns remain regarding medical-cost inflation, flat Medicare Advantage pricing, and regulatory risks. Analysts currently rate UNH as a “Moderate Buy” with a consensus price target of $372.13.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)